Hoerter Steven L.

President and CEO at Deciphera Pharmaceuticals, Inc.; Chief Commercial Officer at AGIO; Officer at Clovis Oncology, Inc.

Sold, on record
$9.4M
Dollars the filings state
Form 4 sales
18
Latest Dec 13, 2023
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AGIOUnusual
    Jun 22, 2018 2018

    Sold 2,050 shares at $97.58 ($200k)

    Hoerter Steven L., Chief Commercial Officer

    Sold 100% of holdings ($200k position)0 shares left1x usual sizeFiling

  2. 2 Form 4 sale AGIOUnusual
    Jul 25, 2018 +33 days

    Sold 2,050 shares at $84.58 ($173k)

    Hoerter Steven L., Chief Commercial Officer

    Sold 100% of holdings ($173k position)0 shares left1x usual sizeFiling

  3. 3 Form 4 sale AGIOUnusual
    Aug 24, 2018 +30 days

    Sold 2,050 shares at $74.92 ($154k)

    Hoerter Steven L., Chief Commercial Officer

    Sold 100% of holdings ($154k position)0 shares left1x usual sizeFiling

  4. 4 Form 4 sale AGIOUnusual
    Mar 4, 2019 +192 days

    Sold 10,000 shares at $67.01 ($670k)

    Hoerter Steven L., Chief Commercial Officer

    Sold 47.8% of holdings ($1.4M position)10,941 shares left4.9x usual sizeFiling

  5. 5 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Feb 14, 2023 +1443 days

    Sold 30,045 shares at $16.00 ($481k)

    Hoerter Steven L., President and CEO

    Sold 80% of holdings ($601k position)7,500 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Mar 21, 2023 +35 days

    Sold 7,500 shares at $15.57 ($117k)

    Hoerter Steven L., President and CEO

    No 10b5-1 planSold 100% of holdings ($117k position)0 shares leftFiling

  7. 7 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Oct 30, 2023 +223 days

    Sold 21,573 shares at $12.02 ($259k)

    Hoerter Steven L., President and CEO

    No 10b5-1 planSold 34.5% of holdings ($751k position)40,927 shares leftFiling

  8. 8 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Dec 13, 2023 +44 days

    Sold 30,664 shares at $15.37 ($471k)

    Hoerter Steven L., President and CEO

    No 10b5-1 planSold 29.6% of holdings ($1.6M position)72,763 shares left1.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (18)

Form 144 notices and Form 4 sales by Hoerter Steven L.
Source
Dec 13, 2023Dec 14, 2023Deciphera Pharmaceuticals, Inc.President and CEOForm 4 sale30,664$471k29.6%UnusualSEC
Oct 30, 2023Oct 31, 2023Deciphera Pharmaceuticals, Inc.President and CEOForm 4 sale21,573$259k34.5%UnusualSEC
Mar 21, 2023Mar 23, 2023Deciphera Pharmaceuticals, Inc.President and CEOForm 4 sale7,500$117k100.0%UnusualSEC
Feb 14, 2023Feb 16, 2023Deciphera Pharmaceuticals, Inc.President and CEOForm 4 sale30,045$481k80.0%UnusualSEC
Mar 4, 2019Mar 5, 2019AGIOChief Commercial OfficerForm 4 sale10,000$670k47.8%UnusualSEC
Aug 24, 2018Aug 28, 2018AGIOChief Commercial OfficerForm 4 sale2,050$154k100.0%UnusualSEC
Jul 25, 2018Jul 27, 2018AGIOChief Commercial OfficerForm 4 sale2,050$173k100.0%UnusualSEC
Jun 22, 2018Jun 26, 2018AGIOChief Commercial OfficerForm 4 sale2,050$200k100.0%UnusualSEC
May 23, 2018May 29, 2018AGIOChief Commercial OfficerForm 4 sale2,050$176k100.0%UnusualSEC
Apr 23, 2018Apr 25, 2018AGIOChief Commercial OfficerForm 4 sale2,050$176k100.0%UnusualSEC
Mar 22, 2018Mar 26, 2018AGIOChief Commercial OfficerForm 4 sale2,050$174k100.0%UnusualSEC
Feb 22, 2018Feb 26, 2018AGIOChief Commercial OfficerForm 4 sale2,050$161k100.0%UnusualSEC
Jan 23, 2018Jan 25, 2018AGIOChief Commercial OfficerForm 4 sale25,000$1.9M100.0%UnusualSEC
Mar 5, 2015Mar 9, 2015Clovis Oncology, Inc.OfficerForm 4 sale20,000$1.6M100.0%UnusualSEC
Feb 17, 2015Feb 19, 2015Clovis Oncology, Inc.OfficerForm 4 sale10,000$720k100.0%UnusualSEC
Jan 16, 2015Jan 20, 2015Clovis Oncology, Inc.OfficerForm 4 sale10,000$670k100.0%UnusualSEC
Jan 13, 2015Jan 15, 2015Clovis Oncology, Inc.OfficerForm 4 sale10,000$620k100.0%UnusualSEC
Jun 4, 2013Jun 6, 2013Clovis Oncology, Inc.OfficerForm 4 sale10,000$731k100.0%UnusualSEC